IBDEI13R ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18754,0)
 ;;=H11.231^^82^897^28
 ;;^UTILITY(U,$J,358.3,18754,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18754,1,3,0)
 ;;=3^Symblepharon,Right Eye
 ;;^UTILITY(U,$J,358.3,18754,1,4,0)
 ;;=4^H11.231
 ;;^UTILITY(U,$J,358.3,18754,2)
 ;;=^5004773
 ;;^UTILITY(U,$J,358.3,18755,0)
 ;;=H11.232^^82^897^27
 ;;^UTILITY(U,$J,358.3,18755,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18755,1,3,0)
 ;;=3^Symblepharon,Left Eye
 ;;^UTILITY(U,$J,358.3,18755,1,4,0)
 ;;=4^H11.232
 ;;^UTILITY(U,$J,358.3,18755,2)
 ;;=^5004774
 ;;^UTILITY(U,$J,358.3,18756,0)
 ;;=H04.121^^82^897^13
 ;;^UTILITY(U,$J,358.3,18756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18756,1,3,0)
 ;;=3^Dry Eye Syndrome,Right Lacrimal Gland
 ;;^UTILITY(U,$J,358.3,18756,1,4,0)
 ;;=4^H04.121
 ;;^UTILITY(U,$J,358.3,18756,2)
 ;;=^5004463
 ;;^UTILITY(U,$J,358.3,18757,0)
 ;;=H04.122^^82^897^12
 ;;^UTILITY(U,$J,358.3,18757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18757,1,3,0)
 ;;=3^Dry Eye Syndrome,Left Lacrimal Gland
 ;;^UTILITY(U,$J,358.3,18757,1,4,0)
 ;;=4^H04.122
 ;;^UTILITY(U,$J,358.3,18757,2)
 ;;=^5004464
 ;;^UTILITY(U,$J,358.3,18758,0)
 ;;=H04.123^^82^897^11
 ;;^UTILITY(U,$J,358.3,18758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18758,1,3,0)
 ;;=3^Dry Eye Syndrome,Bilateral Lacrimal Glands
 ;;^UTILITY(U,$J,358.3,18758,1,4,0)
 ;;=4^H04.123
 ;;^UTILITY(U,$J,358.3,18758,2)
 ;;=^5004465
 ;;^UTILITY(U,$J,358.3,18759,0)
 ;;=H15.111^^82^897^16
 ;;^UTILITY(U,$J,358.3,18759,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18759,1,3,0)
 ;;=3^Episcleritis Periodica Fugax,Right Eye
 ;;^UTILITY(U,$J,358.3,18759,1,4,0)
 ;;=4^H15.111
 ;;^UTILITY(U,$J,358.3,18759,2)
 ;;=^5004838
 ;;^UTILITY(U,$J,358.3,18760,0)
 ;;=H15.112^^82^897^15
 ;;^UTILITY(U,$J,358.3,18760,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18760,1,3,0)
 ;;=3^Episcleritis Periodica Fugax,Left Eye
 ;;^UTILITY(U,$J,358.3,18760,1,4,0)
 ;;=4^H15.112
 ;;^UTILITY(U,$J,358.3,18760,2)
 ;;=^5004839
 ;;^UTILITY(U,$J,358.3,18761,0)
 ;;=H15.113^^82^897^14
 ;;^UTILITY(U,$J,358.3,18761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18761,1,3,0)
 ;;=3^Episcleritis Periodica Fugax,Bilateral
 ;;^UTILITY(U,$J,358.3,18761,1,4,0)
 ;;=4^H15.113
 ;;^UTILITY(U,$J,358.3,18761,2)
 ;;=^5004840
 ;;^UTILITY(U,$J,358.3,18762,0)
 ;;=T15.02XA^^82^897^17
 ;;^UTILITY(U,$J,358.3,18762,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18762,1,3,0)
 ;;=3^FB in Cornea,Left Eye,Init Encntr
 ;;^UTILITY(U,$J,358.3,18762,1,4,0)
 ;;=4^T15.02XA
 ;;^UTILITY(U,$J,358.3,18762,2)
 ;;=^5046387
 ;;^UTILITY(U,$J,358.3,18763,0)
 ;;=T15.01XA^^82^897^18
 ;;^UTILITY(U,$J,358.3,18763,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18763,1,3,0)
 ;;=3^FB in Cornea,Right Eye,Init Encntr
 ;;^UTILITY(U,$J,358.3,18763,1,4,0)
 ;;=4^T15.01XA
 ;;^UTILITY(U,$J,358.3,18763,2)
 ;;=^5046384
 ;;^UTILITY(U,$J,358.3,18764,0)
 ;;=E11.9^^82^898^20
 ;;^UTILITY(U,$J,358.3,18764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18764,1,3,0)
 ;;=3^DM 2 w/o Ophth Manif
 ;;^UTILITY(U,$J,358.3,18764,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,18764,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,18765,0)
 ;;=E11.359^^82^898^17
 ;;^UTILITY(U,$J,358.3,18765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18765,1,3,0)
 ;;=3^DM 2 w/ PDR w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,18765,1,4,0)
 ;;=4^E11.359
 ;;^UTILITY(U,$J,358.3,18765,2)
 ;;=^5002641
 ;;^UTILITY(U,$J,358.3,18766,0)
 ;;=E11.351^^82^898^16
 ;;^UTILITY(U,$J,358.3,18766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18766,1,3,0)
 ;;=3^DM 2 w/ PDR w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,18766,1,4,0)
 ;;=4^E11.351
 ;;^UTILITY(U,$J,358.3,18766,2)
 ;;=^5002640
